Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Baseline characteristics of the included study populationPatient characteristicsTotal157 Age, median (IQR)75.3 (70.8 to 80.8) Male gender, n (%)103 (65.6) Caucasian origin, n (%)138 (89.0) Married/living together, n (%)94 (61.4) Higher Educational level, n (%)48 (30.6) Current smoking23 (15.0) Alcohol consumption77 (50.3)Disease specific eGFR at study enrolment, mean (SD)16.2 (4.4) Δ eGFR (ml/min), mean (SD)a9.1 (8.0)Primairy kidney disease Non-vascular cause, n (%)56 (35.7) Vascular cause, n (%)99 (63.1) Diabetes mellitus, n (%)63 (40.1) (history of) malignancy, n (%)47 (29.9) History of vascular disease, (n%)74 (47.4) Ankle-brachial index (right), mean (SD)0.96 (0.23)Medication use Polypharmacy (the use of ≥5 medications), n (%)139 (89.7) Glucose lowering medication, n (%)54 (34.4) Antihypertensive medication, n (%)145 (92.4) Diuretics, n (%)94 (60.3) Cholesterol lowering drugs, n (%)112 (71.3) Vitamin D supplement, n (%)131 (83.4)Nutrition status Normal Subjective Global Assessment (SGA) score42 (49.4)SNAQ score Malnourished8 (10.7) Risk for malnutrition9 (12.0) BMI, median (IQR)27.4 (24.6 to 30.9) Special diet, n (%)127 (83.0)Geriatric assessment Frail according to FFI, n (%)37 (24.5) Functional dependence by GARS-score, mean (IQR)26 (20.0 to 35.0) Dependent in IADL function, n (%)8 (5.0)Handgrip strength (kg), mean (SD) Females17.2 (6.3) Males29.4 (8.1) Walking speed, mean (SD) (m/s)1.13 (0.98)aΔ eGFR = difference between eGFR 3 years before and at study enrolment.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The COPE-study (Cognitive Decline in Older Patients with ESRD) is a prospective cohort study including 157 participants aged 65 years and older approaching ESKD (eGFR ≤20 ml/min/1.73 m2) prior to starting with RRT.
Source: Abstract.
In brief, the COPE study is a prospective, multicentre cohort study in five hospitals in the Netherlands in patients aged 65 years and older reaching ESRD (estimated glomerular filtration rate (eGFR) ≤ 20 ml/min/1.73 m2), and attending the pre-dialysis outpatient between April 2014 and December 2017.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Patterns and characteristics of cognitive functioning in older patients approaching end stage kidney disease, the COPE-study
Cohort study · BMC Nephrology · 2020
Original publication title
Patterns and characteristics of cognitive functioning in older patients approaching end stage kidney disease, the COPE-study
© The Author(s) 2020
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
The prevalence of impaired cognitive functioning in older patients with end stage kidney disease (ESKD) is high. We aim to describe patterns of memory, executive function or psychomotor speed and to identify nephrologic, geriatric and neuroradiologic characteristics associated with cognitive impairment in older patients approaching ESKD who have not yet started with renal replacement therapy (RRT).
Source: BackgroundAbstract: What methods does the paper describe?
The COPE-study (Cognitive Decline in Older Patients with ESRD) is a prospective cohort study including 157 participants aged 65 years and older approaching ESKD (eGFR ≤20 ml/min/1.73 m2) prior to starting with RRT. In addition to routinely collected clinical parameters related to ESKD, such as vascular disease burden and parameters of metabolic disturbance, patients received a full geriatric assessment, including extensive neuropsychological testing. In a subgroup of patients (n = 93) a brain MRI was performed.
Source: MethodsAbstract: Results
The median age was 75.3 years. Compared to the normative data of neuropsychological testing participants memory performance was in the 24th percentile, executive function in the 18th percentile and psychomotor speed in the 20th percentile. Independent associated characteristics of impairment in memory, executive and psychomotor speed were high age, low educational level and low functional status (all p-values < 0.003). A history of vascular disease (p = 0.007) and more white matter hyperintensities on brain MRI (p = 0.013) were associated with a lower psychomotor speed.
Source: ResultsAbstract: Conclusion
Older patients approaching ESKD have a high prevalence of impaired memory, executive function and psychomotor speed. The patterns of cognitive impairment and brain changes on MRI are suggestive of vascular cognitive impairment. These findings could be of potentially added value in the decision-making process concerning patients with ESKD.
Source: ConclusionAuthors’ abstract
Background
The prevalence of impaired cognitive functioning in older patients with end stage kidney disease (ESKD) is high. We aim to describe patterns of memory, executive function or psychomotor speed and to identify nephrologic, geriatric and neuroradiologic characteristics associated with cognitive impairment in older patients approaching ESKD who have not yet started with renal replacement therapy (RRT).
Methods
The COPE-study (Cognitive Decline in Older Patients with ESRD) is a prospective cohort study including 157 participants aged 65 years and older approaching ESKD (eGFR ≤20 ml/min/1.73 m2) prior to starting with RRT. In addition to routinely collected clinical parameters related to ESKD, such as vascular disease burden and parameters of metabolic disturbance, patients received a full geriatric assessment, including extensive neuropsychological testing. In a subgroup of patients (n = 93) a brain MRI was performed.
Results
The median age was 75.3 years. Compared to the normative data of neuropsychological testing participants memory performance was in the 24th percentile, executive function in the 18th percentile and psychomotor speed in the 20th percentile. Independent associated characteristics of impairment in memory, executive and psychomotor speed were high age, low educational level and low functional status (all p-values < 0.003). A history of vascular disease (p = 0.007) and more white matter hyperintensities on brain MRI (p = 0.013) were associated with a lower psychomotor speed.
Conclusion
Older patients approaching ESKD have a high prevalence of impaired memory, executive function and psychomotor speed. The patterns of cognitive impairment and brain changes on MRI are suggestive of vascular cognitive impairment. These findings could be of potentially added value in the decision-making process concerning patients with ESKD.
Publication and source details
Original title: Patterns and characteristics of cognitive functioning in older patients approaching end stage kidney disease, the COPE-study
Floor J. van Deudekom; Marije H. Kallenberg; Noeleen C. Berkhout-Byrne; Gerard J. Blauw; Henk Boom; Jeroen de Bresser; Mark A. van Buchem; André Gaasbeek; Sebastiaan Hammer; Joep Lagro; Matthias J. P. van Osch; Marie-Noëlle Witjes-Ané; Ton J. Rabelink; Marjolijn van Buren; Simon P. Mooijaart
BMC Nephrology · 2020
© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100001826ZonMw62700.3001Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T17:52:07.910767+00:00
DOI: 10.1186/s12882-020-01764-2 · PMC7147053